TAFAZZIN and cardiac arrhythmia: Since deficiencies of either ACADVL [8, 77] or CPT2 [59] can cause cardiomyopathy and arrhythmias in newborns and early infancy, the substantial reduction of FA uptake and oxidation in BTHS hearts likely contributes to the cardiomyopathy phenotype.